Deutsche Bank raises Biohaven target price to $26 from $20
BHVN•Deutsche Bank raised its target price for Biohaven to $26 from $20.
Related News
First American Financial Corp: Truist Securities cuts target price to $78 from $80
FAF•
JAKKS Pacific declares quarterly cash dividend of $0.25 per share
JAKK•
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug
ZYME•
UBS cuts total voting rights in Renk to 4.71% from 5.06%
UBS•
Diodes Incorporated coverage initiated with buy rating and $110 target price
DIOD•